Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion type Assertion NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_head.
- NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion description "[These results suggest that FGF21 could be a novel and attractive drug candidate for the treatment of cardiovascular disease, obesity and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_provenance.
- NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion evidence source_evidence_literature NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_provenance.
- NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion SIO_000772 19337957 NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_provenance.
- NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion wasDerivedFrom befree-20140225 NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_provenance.
- NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_assertion wasGeneratedBy ECO_0000203 NP525653.RAqUPxi7z6dcoRss0xcbi9oXukw5myGl4xDi3zTUDmVFE130_provenance.